Skip to main content
July 20, 2017

Telerehabilitation helps healthcare professionals reach more patients in need, but some worry it doesn’t offer the same quality of care as in-person treatment. This isn’t the case, according to recent research by Baycrest.

The study, published in the journal Aphasiology, found that patients who accessed speech language therapy over the Internet saw large improvements to their communication abilities that were similar to those of patients doing in-person therapy.

This finding encourages greater adoption of telerehabilitation to treat patients living in remote communities who are recovering from post-stroke communication disorders as a way to improve the use of limited healthcare resources.

“People with communication disorders, such as aphasia, are often provided with therapy only for the first few months after they have been diagnosed, despite evidence that therapy can benefit them for years, says Dr. Jed Meltzer, lead author and neurorehabilitation scientist at Baycrest’s Rotman Research Institute. “Location can limit a patient’s access to a speech-language pathologist, especially for individuals living in rural areas. Our study shows that telerehabilitation can remove this geographic barrier since participants saw similar recovery results.

Despite these comparable improvements, an unexpected finding was that patients who did telerehabilitation therapy weren’t as confident in their communication abilities compared to those who did in-person treatment.

“Low confidence can lead to continued isolation and it is important that patients be encouraged to find other ways to socially engage with others beyond their therapy, says Dr. Meltzer, who is also an assistant professor at the University of Toronto’s Department of Psychology and Speech Language Pathology.

Based on the study’s findings, Dr. Meltzer suggests that speech-language pathologists continue to play a critical role in the creation and supervision of treatment for patients and computer-based or tablet-based applications can help handle day-to-day treatment exercises.

The study analyzed the recovery of 44 patients who had a communication disorder caused by a stroke at least six months prior to recruitment. All patients received an in-person assessment and participated in a language skills test in the first week of therapy. They were then assigned either telerehabilitation or in-person treatment for 10 weeks. Once treatment was completed, each patient completed a language skills test and a questionnaire. Their partners also provided feedback about the patient’s recovery.

As the only Ontario hospital offering one of the few clinically validated, gold standard telerehabilitation programs for Parkinson’s patients, the Lee Silverman Voice Treatment (LSVT®) eLOUD Clinic, offering telerehabilitation services at Baycrest allows clinicians to help more patients. “Older adults may face mobility issues and have a difficult time travelling to a specific location for treatment, says Maria Piccini, a Baycrest speech-language pathologist who runs the LSVT® Clinic. “Telerehabilitation makes it easier for these individuals to access the therapy they need and improves their chances of completing the treatment.

These findings support Dr. Meltzer’s next steps which involve combining telerehabilitation technology with other therapies, such as medication or brain stimulation, to explore ways to provide more efficient treatment to patients.

This research was conducted with support from the Heart and Stroke Foundation Canadian Partnership for Stroke Recovery, the Manitoba Patient Access Network, Speechworks Inc. and Lingraphica Inc., which covered recruitment costs and provided patients access to a speech-language pathologist, telehealth equipment, technology that participants used to complete homework and aphasia treatment software.

Additional funding could support the creation of new language rehabilitation software to help patients practice at home. Support Dr. Meltzer’s work by donating online or calling the donations line at 416-785-2875.

About Baycrest Health Sciences
Baycrest Health Sciences is a global leader in geriatric residential living, healthcare, research, innovation and education, with a special focus on brain health and aging. Fully affiliated with the University of Toronto, Baycrest provides excellent care for older adults combined with an extensive clinical training program for the next generation of healthcare professionals and one of the world’s top research institutes in cognitive neuroscience, the Rotman Research Institute. Baycrest is home to the federally and provincially-funded Canadian Centre for Aging and Brain Health Innovation, a solution accelerator focused on driving innovation in the aging and brain health sector, and is the developer of Cogniciti – a free online memory assessment for Canadians 40+ who are concerned about their memory.  Founded in 1918 as the Jewish Home for Aged, Baycrest continues to embrace the long-standing tradition of all great Jewish healthcare institutions to improve the well-being of people in their local communities and around the globe. For more information please visit:

About Baycrest’s Rotman Research Institute
The Rotman Research Institute at Baycrest Health Sciences is a premier international centre for the study of human brain function. Through generous support from private donors and funding agencies, the institute is helping to illuminate the causes of cognitive decline in seniors, identify promising approaches to treatment, and lifestyle practices that will protect brain health longer in the lifespan.

For media inquiries:
Jonathan MacIndoe
Baycrest Health Sciences
416-785-2500 ext. 6579

Next Article